Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Assessment of Unani Formulation 'Dolabi' in Management of Diabetes Mellitus Type II

NCT06841497 is registered in ClinicalTrials.gov with Hamdard University as lead sponsor.

NCT NCT06841497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06841497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Assessment of Unani Formulation 'Dolabi' in Management of Diabetes Mellitus Type II
Lead sponsor
Hamdard University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 4, 2024
Completion date
October 3, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2 dm